186 related articles for article (PubMed ID: 1649573)
1. Spontaneous quinolone resistance in Serratia marcescens due to a mutation in gyrA.
Masecar BL; Robillard NJ
Antimicrob Agents Chemother; 1991 May; 35(5):898-902. PubMed ID: 1649573
[TBL] [Abstract][Full Text] [Related]
2. Cloning and nucleotide sequence of the DNA gyrase gyrA gene from Serratia marcescens and characterization of mutations in gyrA of quinolone-resistant clinical isolates.
Kim JH; Cho EH; Kim KS; Kim HY; Kim YM
Antimicrob Agents Chemother; 1998 Jan; 42(1):190-3. PubMed ID: 9449286
[TBL] [Abstract][Full Text] [Related]
3. Ciprofloxacin and the fluoroquinolones. New concepts on the mechanism of action and resistance.
Fisher LM; Lawrence JM; Josty IC; Hopewell R; Margerrison EE; Cullen ME
Am J Med; 1989 Nov; 87(5A):2S-8S. PubMed ID: 2574005
[TBL] [Abstract][Full Text] [Related]
4. Detection of mutations in the gyrA and parC genes in quinolone-resistant clinical isolates of Enterobacter cloacae.
Deguchi T; Yasuda M; Nakano M; Ozeki S; Kanematsu E; Nishino Y; Ishihara S; Kawada Y
J Antimicrob Chemother; 1997 Oct; 40(4):543-9. PubMed ID: 9372424
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic characterization of quinolone-resistant mutants of Enterobacteriaceae selected from wild type, gyrA type and multiply-resistant (marA) type strains.
Piddock LJ; Hall MC; Walters RN
J Antimicrob Chemother; 1991 Aug; 28(2):185-98. PubMed ID: 1663926
[TBL] [Abstract][Full Text] [Related]
6. Evidence of an efflux pump in Serratia marcescens.
Berlanga M; Vázquez JL; Hernandez-Borrell J; Montero MT; Viñas M
Microb Drug Resist; 2000; 6(2):111-7. PubMed ID: 10990265
[TBL] [Abstract][Full Text] [Related]
7. New Escherichia coli gyrA and gyrB mutations which have a graded effect on DNA supercoiling.
Aleixandre V; Urios A; Herrera G; Blanco M
Mol Gen Genet; 1989 Oct; 219(1-2):306-12. PubMed ID: 2559316
[TBL] [Abstract][Full Text] [Related]
8. Broad-host-range gyrase A gene probe.
Robillard NJ
Antimicrob Agents Chemother; 1990 Oct; 34(10):1889-94. PubMed ID: 1963286
[TBL] [Abstract][Full Text] [Related]
9. A novel, double mutation in DNA gyrase A of Escherichia coli conferring resistance to quinolone antibiotics.
Truong QC; Nguyen Van JC; Shlaes D; Gutmann L; Moreau NJ
Antimicrob Agents Chemother; 1997 Jan; 41(1):85-90. PubMed ID: 8980760
[TBL] [Abstract][Full Text] [Related]
10. Impact of gyrA and parC mutations on quinolone resistance, doubling time, and supercoiling degree of Escherichia coli.
Bagel S; Hüllen V; Wiedemann B; Heisig P
Antimicrob Agents Chemother; 1999 Apr; 43(4):868-75. PubMed ID: 10103193
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the mechanisms of quinolone resistance in clinical isolates of Citrobacter freundii.
Navia MM; Ruiz J; Ribera A; de Anta MT; Vila J
J Antimicrob Chemother; 1999 Dec; 44(6):743-8. PubMed ID: 10590274
[TBL] [Abstract][Full Text] [Related]
12. Use of a broad-host-range gyrA plasmid for genetic characterization of fluoroquinolone-resistant gram-negative bacteria.
Heisig P; Wiedemann B
Antimicrob Agents Chemother; 1991 Oct; 35(10):2031-6. PubMed ID: 1759823
[TBL] [Abstract][Full Text] [Related]
13. Activities of trovafloxacin compared with those of other fluoroquinolones against purified topoisomerases and gyrA and grlA mutants of Staphylococcus aureus.
Gootz TD; Zaniewski RP; Haskell SL; Kaczmarek FS; Maurice AE
Antimicrob Agents Chemother; 1999 Aug; 43(8):1845-55. PubMed ID: 10428901
[TBL] [Abstract][Full Text] [Related]
14. Quinolone resistance mutations in the DNA gyrase gyrA and gyrB genes of Staphylococcus aureus.
Ito H; Yoshida H; Bogaki-Shonai M; Niga T; Hattori H; Nakamura S
Antimicrob Agents Chemother; 1994 Sep; 38(9):2014-23. PubMed ID: 7811012
[TBL] [Abstract][Full Text] [Related]
15. Development of a rapid assay for detecting gyrA mutations in Escherichia coli and determination of incidence of gyrA mutations in clinical strains isolated from patients with complicated urinary tract infections.
Ozeki S; Deguchi T; Yasuda M; Nakano M; Kawamura T; Nishino Y; Kawada Y
J Clin Microbiol; 1997 Sep; 35(9):2315-9. PubMed ID: 9276409
[TBL] [Abstract][Full Text] [Related]
16. In vitro selection of fluoroquinolone-resistant Neisseria gonorrhoeae harboring alterations in DNA gyrase and topoisomerase IV.
Yasuda M; Fukuda H; Yokoi S; Ishihara S; Kawada Y; Deguchi T
J Urol; 2000 Sep; 164(3 Pt 1):847-51. PubMed ID: 10953166
[TBL] [Abstract][Full Text] [Related]
17. Quinolone action in Escherichia coli cells carrying gyrA and gyrB mutations.
Herrera G; Aleixandra V; Urios A; Blanco M
FEMS Microbiol Lett; 1993 Jan; 106(2):187-91. PubMed ID: 8384139
[TBL] [Abstract][Full Text] [Related]
18. Quinolone-resistant mutants of escherichia coli DNA topoisomerase IV parC gene.
Kumagai Y; Kato JI; Hoshino K; Akasaka T; Sato K; Ikeda H
Antimicrob Agents Chemother; 1996 Mar; 40(3):710-14. PubMed ID: 8851598
[TBL] [Abstract][Full Text] [Related]
19. Novel gyrA point mutation in a strain of Escherichia coli resistant to fluoroquinolones but not to nalidixic acid.
Cambau E; Bordon F; Collatz E; Gutmann L
Antimicrob Agents Chemother; 1993 Jun; 37(6):1247-52. PubMed ID: 8392306
[TBL] [Abstract][Full Text] [Related]
20. Quinolone resistance in clinical isolates of Serratia marcescens.
Fujimaki K; Fujii T; Aoyama H; Sato K; Inoue Y; Inoue M; Mitsuhashi S
Antimicrob Agents Chemother; 1989 May; 33(5):785-7. PubMed ID: 2546493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
